Sorrento Therapeutics Inc (NASDAQ:SRNE)

9.10
Delayed Data
As of Feb 23
 +0.70 / +8.33%
Today’s Change
1.50
Today|||52-Week Range
9.55
+139.47%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 19.50, with a high estimate of 30.00 and a low estimate of 9.00. The median estimate represents a +114.29% increase from the last price of 9.10.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$12.7M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -131.82%
 
 
 
 
 
 
Growthannually 80.99%
 
 
 
 
 
 

Sales

Growthquarterly -89.56%
 
 
 
 
 
 
Growthannually 1,668.66%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.